Microbial drug resistance最新文献

筛选
英文 中文
Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative Klebsiella pneumoniae Isolates from Orthopedic Patients. 比较氟喹诺酮类药物对骨科患者中 ESBL 阳性和 ESBL 阴性肺炎克雷伯菌的突变预防浓度。
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-09-01 Epub Date: 2024-07-17 DOI: 10.1089/mdr.2024.0023
Peng Zou, Zhiquan Chen, Jijun Tu, Xinfeng Chen, Xuejian Liu
{"title":"Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative <i>Klebsiella pneumoniae</i> Isolates from Orthopedic Patients.","authors":"Peng Zou, Zhiquan Chen, Jijun Tu, Xinfeng Chen, Xuejian Liu","doi":"10.1089/mdr.2024.0023","DOIUrl":"10.1089/mdr.2024.0023","url":null,"abstract":"<p><p>The majority of <i>Klebsiella pneumonia</i> isolates possess the extended-spectrum beta-lactamase (ESBL) enzymes. Therefore, <i>K. pneumoniae</i> can easily develop drug resistance. How to effectively overcome the problem of drug resistance in <i>K. pneumoniae</i> is still a research hotspot. This study aimed to compare the mutant prevention concentration (MPC) of ESBL-positive and ESBL-negative <i>K. pneumoniae</i> isolated from orthopedic patients, which may provide a basis for the effective use of drugs to control the enrichment of resistance mutants of <i>K. pneumoniae</i>. The MPC<sub>90</sub> values of 55 isolates of ESBL-positive <i>K. pneumoniae</i> against 4 fluoroquinolones were 32 µg/mL for levofloxacin and gatifloxacin, 16 µg/mL for ciprofloxacin, and 4 µg/mL for gemifloxacin. The selection index value was 8 for levofloxacin and ciprofloxacin and 2 for gemifloxacin and gatifloxacin, respectively. For ESBL-negative <i>K. pneumoniae</i> isolates, the MPC<sub>90</sub> values were 16 µg/mL for levofloxacin and ciprofloxacin, 4 µg/mL for gemifloxacin, and 32 µg/mL for gatifloxacin. The selection index value was 8 for levofloxacin and ciprofloxacin, 2 for gemifloxacin, and 4 for gatifloxacin. For the ESBL-positive <i>K. pneumoniae</i>, the %T>MIC<sub>90</sub> order was gemifloxacin > levofloxacin > ciprofloxacin > gatifloxacin. For the ESBL-negative <i>K. pneumoniae,</i> the %T>MIC<sub>90</sub> order was levofloxacin > gemifloxacin > ciprofloxacin > gatifloxacin. The mutant-preventing ability of gatifloxacin and gemifloxacin was the strongest among the 4 fluoroquinolones. So gemifloxacin may be the first choice of drug to treat <i>K. pneumoniae</i> infection.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"391-397"},"PeriodicalIF":2.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Microbial Drug Resistance. 罗莎琳德-富兰克林学会自豪地宣布 2023 年微生物抗药性奖获得者。
IF 2.6 4区 医学
Microbial drug resistance Pub Date : 2024-09-01 DOI: 10.1089/mdr.2024.44723.rfs2023
Dr Anna Carannante
{"title":"Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Microbial Drug Resistance.","authors":"Dr Anna Carannante","doi":"10.1089/mdr.2024.44723.rfs2023","DOIUrl":"https://doi.org/10.1089/mdr.2024.44723.rfs2023","url":null,"abstract":"","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"8 1","pages":"353"},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates. 临床分离菌 Achromobacter spp.、Burkholderia spp.和 Stenotrophomonas maltophilia 的生物膜和浮游细胞的耐药性。
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-09-01 Epub Date: 2024-07-19 DOI: 10.1089/mdr.2023.0301
Edeer Iván Montoya-Hinojosa, Licet Villarreal-Treviño, Paola Bocanegra-Ibarias, Adrián Camacho-Ortiz, Samantha Flores-Treviño
{"title":"Drug Resistance in Biofilm and Planktonic Cells of <i>Achromobacter</i> spp., <i>Burkholderia</i> spp., and <i>Stenotrophomonas maltophilia</i> Clinical Isolates.","authors":"Edeer Iván Montoya-Hinojosa, Licet Villarreal-Treviño, Paola Bocanegra-Ibarias, Adrián Camacho-Ortiz, Samantha Flores-Treviño","doi":"10.1089/mdr.2023.0301","DOIUrl":"10.1089/mdr.2023.0301","url":null,"abstract":"<p><p><b><i>Background:</i></b> Biofilm production in nonfermenting Gram-negative bacteria influences drug resistance. The aim of this work was to evaluate the effect of different antibiotics on biofilm eradication of clinical isolates of <i>Achromobacter</i>, <i>Burkholderia</i>, and <i>Stenotrophomonas maltophilia</i>. <b><i>Methods:</i></b> Clinical isolates were identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry in a third-level hospital in Monterrey, Mexico. Crystal violet staining was used to determine biofilm production. Drug susceptibility testing was determined by broth microdilution in planktonic cells and biofilm cells. <b><i>Results:</i></b> Resistance in planktonic cells was moderate to trimethoprim-sulfamethoxazole, and low to chloramphenicol, minocycline, levofloxacin (<i>S. maltophilia</i> and <i>Burkholderia</i>), ceftazidime, and meropenem (<i>Burkholderia</i> and <i>Achromobacter</i>). Biofilm eradication required higher drug concentrations of ceftazidime, chloramphenicol, levofloxacin, and trimethoprim-sulfamethoxazole than planktonic cells (<i>p</i> < 0.05). Levofloxacin showed biofilm eradication activity in <i>S. maltophilia,</i> minocycline and meropenem in <i>Burkholderia</i>, and meropenem in <i>Achromobacter</i>. <b><i>Conclusions:</i></b> Drug resistance increased due to biofilm production for some antibiotics, particularly ceftazidime and trimethoprim-sulfamethoxazole for all three pathogens, chloramphenicol for <i>S. maltophilia</i> and <i>Burkholderia,</i> and levofloxacin for <i>Burkholderia.</i> Some antibiotics could be used for the treatment of biofilm-associated infections in our population, such as levofloxacin for <i>S. maltophilia,</i> minocycline and meropenem for <i>Burkholderia</i>, and meropenem for <i>Achromobacter</i>.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"354-362"},"PeriodicalIF":2.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioflavonoid Baicalein Modulates Tetracycline Resistance by Inhibiting Efflux Pump in Staphylococcus aureus. 生物黄酮黄芩素通过抑制金黄色葡萄球菌的外排泵调节四环素耐药性
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-09-01 Epub Date: 2024-08-12 DOI: 10.1089/mdr.2024.0099
Soumitra Moulick, Dijendra Nath Roy
{"title":"Bioflavonoid Baicalein Modulates Tetracycline Resistance by Inhibiting Efflux Pump in <i>Staphylococcus aureus</i>.","authors":"Soumitra Moulick, Dijendra Nath Roy","doi":"10.1089/mdr.2024.0099","DOIUrl":"10.1089/mdr.2024.0099","url":null,"abstract":"<p><p>The rise in antibiotic resistance among bacterial pathogens, particularly <i>Staphylococcus aureus</i>, has become a critical global health issue, necessitating the search for novel antimicrobial agents. <i>S. aureus</i> uses various mechanisms to resist antibiotics, including the activation of efflux pumps, biofilm formation, and enzymatic modification of drugs. This study explores the potential of baicalein, a bioflavonoid from <i>Scutellaria baicalensis</i>, in modulating tetracycline resistance in <i>S. aureus</i> by inhibiting efflux pumps. The synergistic action of baicalein and tetracycline was evaluated through various assays. The minimum inhibitory concentration (MIC) of baicalein and tetracycline against <i>S. aureus</i> was 256 and 1.0 μg/mL, respectively. Baicalein at 64 μg/mL reduced the MIC of tetracycline by eightfold, indicating a synergistic effect (fractional inhibitory concentration index: 0.375). Time-kill kinetics demonstrated a 1.0 log CFU/mL reduction in bacterial count after 24 hours with the combination treatment. The ethidium bromide accumulation assay showed that baicalein mediated significant inhibition of efflux pumps, with a dose-dependent increase in fluorescence. In addition, baicalein inhibited DNA synthesis by 73% alone and 92% in combination with tetracycline. It also markedly reduced biofilm formation and the invasiveness of <i>S. aureus</i> into HeLa cells by 52% at 64 μg/mL. These findings suggest that baicalein enhances tetracycline efficacy and could be a promising adjunct therapy to combat multidrug-resistant <i>S. aureus</i> infections.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"363-371"},"PeriodicalIF":2.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Expression of Efflux Pumps in Pseudomonas aeruginosa in Exposure to Sodium Dodecyl Sulfate, Didecyldimethylammonium Chloride, and Octenidine Dihydrochloride. 评估铜绿假单胞菌在十二烷基硫酸钠、双癸基二甲基氯化铵和盐酸奥替尼啶作用下的外排泵表达。
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI: 10.1089/mdr.2024.0070
Khawla Alsamhary
{"title":"Evaluating the Expression of Efflux Pumps in <i>Pseudomonas aeruginosa</i> in Exposure to Sodium Dodecyl Sulfate, Didecyldimethylammonium Chloride, and Octenidine Dihydrochloride.","authors":"Khawla Alsamhary","doi":"10.1089/mdr.2024.0070","DOIUrl":"10.1089/mdr.2024.0070","url":null,"abstract":"<p><p>Emerging resistance of Gram-negative bacteria, including <i>Pseudomonas aeruginosa</i>, to commonly used detergents and disinfectant is encountering us with hazard. Inappropriate use of disinfectants has forced bacteria to gain resistance. The ability of bacteria to extrude substrates from the cellular interior to the external environment has enabled them to persist in exposure to toxic compounds, which is due to existence of transport proteins. Efflux pumps, in Gram-negative bacteria, are proteins responsible for exporting molecules outside of the cell, by crossing the two membranes. In this study, 40 <i>P. aeruginosa</i> strains from hospitals, clinics, and burn center laundries and 40 <i>P. aeruginosa</i> strains from urban laundries were collected. This study evaluated the minimum inhibitory concentration (MIC) level of sodium dodecyl sulfate (SDS), didecyldimethylammonium chloride (DDAC), and octenidine dihydrochloride (Od) in <i>P. aeruginosa</i> strains. The real-time PCR was carried out to evaluate the expression of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux system. The obtained results indicated a higher MIC level for SDS, DDAC, and Od in medical laundries. The sub-MIC level of DDAC and Od increased the expression level of MexAB-OprM, MexCD-OprJ, and MexXY-OprM in <i>P. aeruginosa</i> strains, suggesting that efflux pumps contribute to disinfectant resistance in <i>P. aeruginosa</i>.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"385-390"},"PeriodicalIF":2.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Third Kuwaiti Multicenter Survey of Antibiotic Susceptibility of Anaerobic Bacteria: A Comparative Analysis of 20-Year Data. 第三次科威特厌氧菌抗生素敏感性多中心调查:20 年数据对比分析》。
IF 2.6 4区 医学
Microbial drug resistance Pub Date : 2024-08-02 DOI: 10.1089/mdr.2024.0036
Khalifa Al Benwan,Wafaa Jamal,May Shahin
{"title":"Third Kuwaiti Multicenter Survey of Antibiotic Susceptibility of Anaerobic Bacteria: A Comparative Analysis of 20-Year Data.","authors":"Khalifa Al Benwan,Wafaa Jamal,May Shahin","doi":"10.1089/mdr.2024.0036","DOIUrl":"https://doi.org/10.1089/mdr.2024.0036","url":null,"abstract":"Objective: This study aimed to evaluate antibiotic susceptibility and antimicrobial resistance trends among clinically significant anaerobes in Kuwait hospitals from 2013 to 2022, comparing these findings with data from 2002 to 2012. Methods: The study prospectively collected 2,317 anaerobic isolates from various body sites across four Kuwaiti hospitals between January 2013 and December 2022. The minimum inhibitory concentrations for 11 antianaerobic antibiotics were determined using E-test methodology. The study analyzed trends and resistance rates across two periods: 2013-2017 and 2018-2022, using statistical analysis for resistance comparison. Results: Of the 2,317 isolates, most were from wounds (42.2%), fluids (28.0%), and tissues (20.5%). Bacteroides fragilis was the most common pathogen (34.0%), followed by Prevotella bivia (13.4%). Over 90% of isolates were susceptible to imipenem, meropenem, tigecycline, and metronidazole, whereas lower susceptibility was observed for penicillin, amoxicillin-clavulanic acid, and clindamycin. Notable differences in resistance profiles since 2002 were observed, especially in amoxicillin-clavulanic acid, piperacillin, piperacillin-tazobactam, and clindamycin. Conclusion: Owing to detected resistance to all antibiotics, susceptibility testing for anaerobic isolates is recommended in severe infections to ensure effective antimicrobial therapy. Continuous surveillance is crucial for developing antibiotic policies to manage invasive anaerobic infections.","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"64 1","pages":"372-384"},"PeriodicalIF":2.6,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Alterations Associated with Colistin Resistance Development in Escherichia coli. 与大肠杆菌产生可乐定抗性有关的基因改变
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-08-01 Epub Date: 2024-06-21 DOI: 10.1089/mdr.2024.0026
Fatemeh Alsahlani, Mehri Haeili
{"title":"Genetic Alterations Associated with Colistin Resistance Development in <i>Escherichia coli</i>.","authors":"Fatemeh Alsahlani, Mehri Haeili","doi":"10.1089/mdr.2024.0026","DOIUrl":"10.1089/mdr.2024.0026","url":null,"abstract":"<p><p><b><i>Background:</i></b> The increased incidence of infections due to multidrug-resistant Gram-negative bacteria has led to the renewed interest in the use of 'forgotten' antibiotics such as colistin. In this work, we studied the chromosomal colistin resistance mechanisms among laboratory-induced colistin-resistant <i>Escherichia coli</i> isolates. <b><i>Methods:</i></b> Three colistin-susceptible (ColS) clinical isolates of <i>E. coli</i> assigning to ST131, ST405, and ST361 were exposed to successively increasing concentrations of colistin. The nucleotide sequences of <i>pmrA</i>, <i>pmrB</i>, <i>pmrD</i>, <i>phoP</i>, <i>phoQ</i>, and <i>mgrB</i> genes were determined. The fitness burden associated with colistin resistance acquisition was determined by measuring the <i>in vitro</i> growth rate. <b><i>Results:</i></b> Colistin resistance induction resulted in 16-64 times increase in colistin MICs in mutants (<i>n</i> = 8) compared with parental isolates. Analysis of chromosomal genes in colistin-resistant mutants compared with those of ColS ancestors revealed genetic alterations confined to PmrAB two-component system and included PmrA G53R/R81S/L105P and PmrB E121K/E121A/A159P/A159V/G302E changes. The PmrB E121 was found as a critical position for colistin resistance development being altered in three mutants with different ancestors. The acquired colistin-resistance phenotype was stable following 10 consecutive passages in the absence of selective pressure of colistin and it did not alter the susceptibility of mutants to other antimicrobial agents. All mutants exhibited growth rates similar to their respective ColS ancestors, except for one isolate, which revealed a significant growth defect. <b><i>Conclusion:</i></b> Our results revealed that colistin resistance in <i>E. coli</i> was more related to PmrAB alterations, which did not impose a fitness cost in most cases.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"325-331"},"PeriodicalIF":2.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of Quinolone Low-Susceptible Haemophilus influenzae Harboring the Mutated Quinolone Targeting Gene of Haemophilus haemolyticus. 携带溶血性嗜血杆菌变异喹诺酮靶向基因的喹诺酮低敏感性流感嗜血杆菌的出现
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-08-01 Epub Date: 2024-05-21 DOI: 10.1089/mdr.2024.0061
Takeaki Wajima, Naoki Hara, Emi Tanaka, Atsuko Shirai, Kei-Ichi Uchiya
{"title":"Emergence of Quinolone Low-Susceptible <i>Haemophilus influenzae</i> Harboring the Mutated Quinolone Targeting Gene of <i>Haemophilus haemolyticus</i>.","authors":"Takeaki Wajima, Naoki Hara, Emi Tanaka, Atsuko Shirai, Kei-Ichi Uchiya","doi":"10.1089/mdr.2024.0061","DOIUrl":"10.1089/mdr.2024.0061","url":null,"abstract":"","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"350-352"},"PeriodicalIF":2.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Increased Prevalence of rmpA Gene in Klebsiella pneumoniae Isolates Coharboring blaNDM and blaOXA-48-like Genes. 肺炎克雷伯菌分离株中同时携带 blaNDM 和 blaOXA-48 类基因的 rmpA 基因的流行率增加。
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-08-01 Epub Date: 2024-05-21 DOI: 10.1089/mdr.2023.0296
Nora M El Naggar, Riham M Shawky, Fathy M E Serry, Mohamed Emara
{"title":"The Increased Prevalence of <i>rmpA</i> Gene in <i>Klebsiella pneumoniae</i> Isolates Coharboring <i>bla</i><sub>NDM</sub> and <i>bla</i><sub>OXA-48-like</sub> Genes.","authors":"Nora M El Naggar, Riham M Shawky, Fathy M E Serry, Mohamed Emara","doi":"10.1089/mdr.2023.0296","DOIUrl":"10.1089/mdr.2023.0296","url":null,"abstract":"<p><p>The emergence of carbapenemase-producing <i>Klebsiella pneumoniae</i> poses a substantial risk to public health. It is essential to comprehend the influence of carbapenemase on the virulence characteristics of <i>K. pneumoniae</i> in order to devise successful strategies for combating these infections. In this study, we explored the distribution disparity of virulence determinants between carbapenemase-producing (CP-Kp, <i>n</i> = 52) and carbapenemase-nonproducing (CN-Kp, <i>n</i> = 43) isolates. The presence of carbapenemases was detected via the modified carbapenem inactivation method and confirmed by PCR. The New Delhi metallo-β-lactamase (<i>bla</i><sub>NDM</sub>) and Oxacillinase-48-like (<i>bla</i><sub>OXA-48-like</sub>) genes were the most prevalent (94.23% and 76.92%, respectively) in CP-Kp isolates. Coexistence of <i>bla</i><sub>NDM</sub> and <i>bla</i><sub>OXA-48-like</sub> was observed in 71.15% of isolates, whereas 5.77% coharbored <i>bla</i><sub>NDM</sub> and <i>bla</i><sub>KPC</sub>. PCR analysis revealed the presence of several virulence genes, including adhesins (<i>fimH</i>, 92.63%, <i>mrkD</i>, 97.89%), capsule-associated virulence (<i>uge</i>, 90.53%), the K2 capsule serotype (<i>k2</i>, 6.32%), the iron acquisition system (<i>kfu</i>, 23.16%), and the regulator of mucoid phenotype (<i>rmpA</i>, 28.42%). A significantly higher prevalence of <i>rmpA</i> was detected in the CP-Kp compared with the CN-Kp (24/52 vs. 3/43, <i>p</i> < 0.0001), indicating a potential association between <i>rmpA</i> and carbapenemase acquisition. In addition, the majority of <i>rmpA</i> (22/24) positive isolates in the CP-Kp isolates coharbored <i>bla</i><sub>NDM</sub> and either <i>bla</i><sub>OXA-48-like</sub> or <i>bla</i><sub>KPC</sub>.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"317-324"},"PeriodicalIF":2.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance of Enterobacteriaceae from Diabetic Foot Infections in a Tunisian Hospital: Detection of E. coli-ST131-blaCTX-M-15 and K. pneumoniae-ST1-blaNDM-1 Strains. 突尼斯一家医院对糖尿病足感染中的肠杆菌科细菌进行监测:大肠杆菌-ST131-blaCTX-M-15和肺炎双球菌-ST1-blaNDM-1菌株的检测。
IF 2.3 4区 医学
Microbial drug resistance Pub Date : 2024-08-01 Epub Date: 2024-05-09 DOI: 10.1089/mdr.2023.0335
Ameni Arfaoui, Sandra Martínez-Álvarez, Idris Nasir Abdullahi, Meha Fethi, Noureddine Sayem, Salma Ben Khelifa Melki, Hadda-Imene Ouzari, Carmen Torres, Naouel Klibi
{"title":"Surveillance of <i>Enterobacteriaceae</i> from Diabetic Foot Infections in a Tunisian Hospital: Detection of <i>E. coli-</i>ST131-<i>bla</i><sub>CTX-M-15</sub> and <i>K. pneumoniae</i>-ST1-<i>bla<sub>NDM-1</sub></i> Strains.","authors":"Ameni Arfaoui, Sandra Martínez-Álvarez, Idris Nasir Abdullahi, Meha Fethi, Noureddine Sayem, Salma Ben Khelifa Melki, Hadda-Imene Ouzari, Carmen Torres, Naouel Klibi","doi":"10.1089/mdr.2023.0335","DOIUrl":"10.1089/mdr.2023.0335","url":null,"abstract":"<p><p>The study determined the prevalence, antimicrobial resistant (AMR) determinants, and genetic characteristics of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolates from patients with diabetic foot infection (DFI) in a Tunisian hospital. A total of 26 <i>Escherichia</i> spp. and <i>Klebsiella</i> spp. isolates were recovered and identified by MALDI-TOF-MS. Antimicrobial susceptibility testing, the detection of AMR determinants and Shiga-like toxin genes, phylogenetic grouping, and molecular typing were performed. Twelve <i>E. coli</i>, 10 <i>K. pneumoniae</i>, 3 <i>K. oxytoca</i>, and 1 <i>E. hermanii</i> were isolated. A multidrug-resistant phenotype was detected in 65.4% of the isolates. About 30.8% of isolates were extended-spectrum β-lactamase (ESBL) producers and mainly carried <i>bla<sub>CTX</sub></i><sub>-M-15</sub> and <i>bla<sub>CTX</sub></i><sub>-M-14</sub> genes. One <i>bla<sub>NDM</sub></i><sub>-1</sub>-producing <i>K. pneumoniae-</i>ST1 strain was identified. Class 1 integrons were detected in 11 isolates and 5 gene cassette arrangements were noted: <i>dfrA1+aadA1</i> (<i>n</i> = 1), <i>dfrA12+aadA2</i> (<i>n</i> = 3), and <i>dfrA17+aadA5</i> (<i>n</i> = 1). Other non-β-lactam resistance genes detected were as follows (number of isolates): <i>aac(3')-II</i> (3), <i>aac(6')-Ib-cr</i>(8), <i>qnrB</i> (2), <i>qnrS</i> (4), <i>cmlA</i> (2), <i>floR</i> (4), <i>sul1</i> (11), <i>sul2</i> (11), and <i>sul3</i> (2). The phylogroup B1 was the most frequent (41.7%) among <i>E. coli</i>, and two ESBL-producing isolates corresponded to the ST131-B2 lineage. The ESBL- and carbapenemase-producing <i>Enterobacteriaceae</i> in DFIs are described for the first time in Tunisia.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"341-349"},"PeriodicalIF":2.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信